Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMasters, K. M.
Right arrow Articles by Edwards, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMasters, K. M.
Right arrow Articles by Edwards, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 18, Issue 13 (July), 2000: 2560-2566
© 2000 American Society for Clinical Oncology

Sentinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is Used

By Kelly M. McMasters, Todd M. Tuttle, David J. Carlson, C. Matthew Brown, R. Dirk Noyes, Rebecca L. Glaser, Donald J. Vennekotter, Peter S. Turk, Peter S. Tate, Armando Sardi, Patricia B. Cerrito, Michael J. Edwards

From the Department of Surgery, Division of Surgical Oncology, J. Graham Brown Cancer Center, and Department of Mathematics, University of Louisville, Louisville, KY; Park Nicollett Clinic, Minneapolis, MN; St. Mary’s Medical Center and Deaconess Hospital, Evansville, IN; Norton Hospital, Louisville, and Central Baptist Hospital, Lexington, KY; LDS Hospital, Salt Lake City, UT; Franciscan Medical Center, Dayton, and Kettering Memorial Hospital, Kettering, OH; Presbyterian Hospital, Charlotte, NC; and St. Agnes Healthcare, Baltimore, MD.

Address reprint requests to Kelly M. McMasters, MD, PhD, University of Louisville-Brown Cancer Center, 529 S Jackson St, Louisville, KY 40202; email kelly.mcmasters{at}nortonhealthcare.org

PURPOSE: Previous studies have demonstrated the feasibility of sentinel lymph node (SLN) biopsy for nodal staging of patients with breast cancer. However, unacceptably high false-negative rates have been reported in several studies, raising doubt about the applicability of this technique in widespread surgical practice. Controversy persists regarding the optimal technique for correctly identifying the SLN. Some investigators advocate SLN biopsy using injection of a vital blue dye, others recommend radioactive colloid, and still others recommend the use of both agents together.

PATIENTS AND METHODS: A total of 806 patients were enrolled by 99 surgeons. SLN biopsy was performed by single-agent (blue dye alone or radioactive colloid alone) or dual-agent injection at the discretion of the operating surgeon. All patients underwent attempted SLN biopsy followed by completion level I/II axillary lymph node dissection to determine the false-negative rate.

RESULTS: There was no significant difference (86% v 90%) in the SLN identification rate among patients who underwent single- versus dual-agent injection. The false-negative rates were 11.8% and 5.8% for single- versus dual-agent injection, respectively (P < .05). Dual-agent injection resulted in a greater mean number of SLNs identified per patient (2.1 v 1.5; P < .0001). The SLN identification rate was significantly less for patients older than 50 years as compared with that of younger patients (87.6% v 92.6%; P = .03). Upper-outer quadrant tumor location was associated with an increased likelihood of a false-negative result compared with all other locations (11.2% v 3.9%; P < .05).

CONCLUSION: In multi-institutional practice, SLN biopsy using dual-agent injection provides optimal sensitivity for detection of nodal metastases. The acceptable SLN identification and false-negative rates associated with the dual-agent injection technique indicate that this procedure is a suitable alternative to routine axillary dissection across a wide spectrum of surgical practice and hospital environments.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
The OncologistHome page
O. Zivanovic, F. Khoury-Collado, N. R. Abu-Rustum, and M. L. Gemignani
Sentinel Lymph Node Biopsy in the Management of Vulvar Carcinoma, Cervical Cancer, and Endometrial Cancer
Oncologist, July 1, 2009; 14(7): 695 - 705.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. M. Sevick-Muraca, R. Sharma, J. C. Rasmussen, M. V. Marshall, J. A. Wendt, H. Q. Pham, E. Bonefas, J. P. Houston, L. Sampath, K. E. Adams, et al.
Imaging of Lymph Flow in Breast Cancer Patients after Microdose Administration of a Near-Infrared Fluorophore: Feasibility Study
Radiology, March 1, 2008; 246(3): 734 - 741.
[Abstract] [Full Text] [PDF]


Home page
Journal of Diagnostic Medical SonographyHome page
K. D. Evans, X. Li, S. R. Robertson, A. M. Boyd, and M. Knopp
Sonographic Assessment of Axillary Lymph Nodes After a Mammographically Recommended Breast Sonogram for Women 55 Years and Older: A Feasibility Study
Journal of Diagnostic Medical Sonography, September 1, 2007; 23(5): 263 - 271.
[Abstract] [PDF]


Home page
CA Cancer J ClinHome page
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Knauer, P. Konstantiniuk, A. Haid, E. Wenzl, M. Riegler-Keil, S. Postlberger, R. Reitsamer, and P. Schrenk
Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy--A Multi-Institutional Validation Study
J. Clin. Oncol., July 20, 2006; 24(21): 3374 - 3380.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
I. Sachelarie, M. L. Grossbard, M. Chadha, S. Feldman, M. Ghesani, and R. H. Blum
Primary Systemic Therapy of Breast Cancer
Oncologist, June 1, 2006; 11(6): 574 - 589.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al.
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7703 - 7720.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. U. Buzdar, K. K. Hunt, D. Berry, and G. N. Hortobagyi
In Reply:
J. Clin. Oncol., September 20, 2005; 23(27): 6804 - 6805.
[Full Text] [PDF]


Home page
JCOHome page
E. P. Mamounas, A. Brown, S. Anderson, R. Smith, T. Julian, B. Miller, H. D. Bear, C. B. Caldwell, A. P. Walker, W. M. Mikkelson, et al.
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
J. Clin. Oncol., April 20, 2005; 23(12): 2694 - 2702.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
N Lamichhane, K W Shen, C L Li, Q X Han, Y J Zhang, Z M Shao, and Z Z Shen
Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid
Postgrad. Med. J., September 1, 2004; 80(947): 546 - 550.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac
Clinical Breast Lymphoscintigraphy: Optimal Techniques for Performing Studies, Image Atlas, and Analysis of Images
RadioGraphics, January 1, 2004; 24(1): 121 - 145.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. T. Kuo, D. S.B. Hoon, H. Takeuchi, R. Turner, H.-J. Wang, D. L. Morton, and B. Taback
Prediction of Disease Outcome in Melanoma Patients by Molecular Analysis of Paraffin-Embedded Sentinel Lymph Nodes
J. Clin. Oncol., October 1, 2003; 21(19): 3566 - 3572.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
E. P. Mamounas
NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions
Clin. Med. Res., October 1, 2003; 1(4): 309 - 326.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. R. Krynyckyi, H. Chun, H. H. Kim, Y. Eskandar, C. K. Kim, and J. Machac
Factors Affecting Visualization Rates of Internal Mammary Sentinel Nodes During Lymphoscintigraphy
J. Nucl. Med., September 1, 2003; 44(9): 1387 - 1393.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
D. K. Blanchard, J. H. Donohue, C. Reynolds, and C. S. Grant
Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast Cancer
Arch Surg, May 1, 2003; 138(5): 482 - 488.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
I. A. Jacobs, C. K. Chang, T. K. DasGupta, and G. Salti
High Isotope Counts and Sentinel Node Positivity in Patients With Melanoma
Arch Surg, January 1, 2003; 138(1): 63 - 66.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Koizumi, M. Makita, M. Yoshimoto, F. Kasumi, G. Sakamoto, and E. Ogata
Indications for Sentinel Lymph Node Biopsy in Patients with Breast Cancer: Retrospective and Simulation Analyses
Jpn. J. Clin. Oncol., December 1, 2002; 32(12): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Lawrence, J. Crawford, F. Sherman, J. A. van der Hage, and C. J.H. van de Velde
Evaluating Neoadjuvant Chemotherapy in Breast Cancer
J. Clin. Oncol., June 15, 2002; 20(12): 2905 - 2907.
[Full Text] [PDF]


Home page
JCOHome page
W. Goessling, P. H. McKee, and R. J. Mayer
Merkel Cell Carcinoma
J. Clin. Oncol., January 15, 2002; 20(2): 588 - 598.
[Full Text] [PDF]


Home page
CMAJHome page
J. Cantin, H. Scarth, M. Levine, and M. Hugi
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy
Can. Med. Assoc. J., July 1, 2001; 165(2): 166 - 173.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, C. Woo, P. B. Cerrito, K. M. McMasters, and for the University of Louisville Breast Cancer Sen
Predicting the Status of the Nonsentinel Axillary Nodes: A Multicenter Study
Arch Surg, May 1, 2001; 136(5): 563 - 568.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. J. Rosser, A. Giuliano, and K. McMasters
Safety of Sentinel Lymph Node Dissection and Significance of Cytokeratin Micrometastases
J. Clin. Oncol., March 15, 2001; 19(6): 1882 - 1883.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2000 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online